Literature DB >> 32840728

m6A RNA Methylation: Ramifications for Gene Expression and Human Health.

R Karthiya1, Piyush Khandelia2.   

Abstract

Cellular transcriptomes are frequently adorned by a variety of chemical modification marks, which in turn have a profound influence on its functioning. Of these modifications, the one which has invited a lot of attention in the recent years is m6A RNA methylation, leading to the development of RNA epigenetics or epitranscriptomics as a frontier research area. m6A RNA methylation is one of the most abundant reversible internal modification seen in cellular RNAs. Studies in the last few years have not only shed light on the molecular machinery involved in m6A RNA methylation but also on the impact of this modification in regulating gene expression and hence biological processes. In this review, we will emphasize the biological impact of this modification in normal organismal development and diseases.

Entities:  

Keywords:  Gene regulation; Reversible RNA modifications; Transcriptome; m6A RNA methylation

Mesh:

Substances:

Year:  2020        PMID: 32840728     DOI: 10.1007/s12033-020-00269-5

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  18 in total

1.  Up-to-date on the evidence linking miRNA-related epitranscriptomic modifications and disease settings. Can these modifications affect cross-kingdom regulation?

Authors:  João Tomé-Carneiro; María-Carmen López de Las Hazas; Hatim Boughanem; Yvonne Böttcher; Akin Cayir; Manuel Macias González; Alberto Dávalos
Journal:  RNA Biol       Date:  2021-11-29       Impact factor: 4.652

2.  Transcriptome-Wide m6A Methylome and m6A-Modified Gene Analysis in Asthma.

Authors:  Deyang Sun; Xiaolu Cai; Fenglin Shen; Liming Fan; Huan Yang; Suqun Zheng; Linshui Zhou; Ke Chen; Zhen Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-30

Review 3.  Emerging role of N4-acetylcytidine modification of RNA in gene regulation and cellular functions.

Authors:  R Karthiya; S Mohammed Wasil; Piyush Khandelia
Journal:  Mol Biol Rep       Date:  2020-11-10       Impact factor: 2.316

4.  Comprehensive Analysis of N6-Methyladenosine Regulators in the Subcluster Classification and Drug Candidates Prediction of Severe Obstructive Sleep Apnea.

Authors:  Niannian Li; Zhenfei Gao; Jinhong Shen; Yuenan Liu; Kejia Wu; Jundong Yang; Shengming Wang; Xiaoman Zhang; Yaxin Zhu; Jingyu Zhu; Jian Guan; Feng Liu; Shankai Yin
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

5.  Comprehensive analysis of the transcriptome-wide m6A methylome in invasive malignant pleomorphic adenoma.

Authors:  Zhenyuan Han; Biao Yang; Qin Wang; Yuhua Hu; Yuqiong Wu; Zhen Tian
Journal:  Cancer Cell Int       Date:  2021-03-02       Impact factor: 5.722

Review 6.  Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma.

Authors:  Enakshi Sivasudhan; Neil Blake; Zhi-Liang Lu; Jia Meng; Rong Rong
Journal:  Front Cell Dev Biol       Date:  2021-04-01

7.  Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling.

Authors:  Lu Yin; Liuzhi Zhou; Shiqi Gao; Yina Feng; Hanzhang Zhu; Jingjing Xiang; Rujun Xu
Journal:  Front Mol Biosci       Date:  2022-02-04

8.  m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma.

Authors:  Deyang Sun; Huan Yang; Liming Fan; Fenglin Shen; Zhen Wang
Journal:  J Cell Mol Med       Date:  2021-10-14       Impact factor: 5.310

9.  Identification of N6-Methylandenosine-Related lncRNAs for Subtype Identification and Risk Stratification in Gastric Adenocarcinoma.

Authors:  Yuancheng Huang; Zehong Yang; Chaoyuan Huang; Xiaotao Jiang; Yanhua Yan; Kunhai Zhuang; Yi Wen; Fengbin Liu; Peiwu Li
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

10.  Interactions of circRNAs with methylation: An important aspect of circRNA biogenesis and function (Review).

Authors:  Chunlei Zhang; Han Cui; Chuang Huang; Feiyan Kong; Qi Yang; Pengcheng Miao; Zhigang Cao; Weijun Zhang; Dehui Chang
Journal:  Mol Med Rep       Date:  2022-03-18       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.